- ... of chemotherapy-associated gonadal toxicity.[ 6 , 7 ] Chemotherapy regimens that do not include alkylating agents such as ABVD (doxorubicin [Adriamycin], bleomycin, vinblastine, dacarbazine), ABVE (doxorubicin [Adriamycin], bleomycin, vincristine, etoposide), OEPA ( ...
- ... for pediatric malignancies.[ 12 - 14 ] More current pediatric regimens for Hodgkin lymphoma using radiation therapy and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) have shown a significant incidence ...
- ... aggressive combination chemotherapy. This chemotherapy generally consisted of vinblastine, bleomycin, and cisplatin; however, some patients received a doxorubicin-containing modification of this regimen and some received etoposide instead of vinblastine. The ...
- ... immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi- ...
- ... achieved partial remissions.[ 33 ] An adult lymphoma treatment regimen of methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisone and bleomycin (MACOP-B) was used in three patients with ...
- ... response rates for systemic treatments were noted: Pegylated doxorubicin: 71% to 100%. Vinca alkaloids: 58% to 90%. Etoposide: 74% to 76%. Taxanes: 93% to 100%. Gemcitabine: 100%. Vinblastine and bleomycin: 97%. Interferon alfa-2: 71% to 100%. For ...
- ... Mitoxantrone. - Nab-paclitaxel. - Necitumumab. - Paclitaxel. - Panitumumab. - ... - Vinblastine. - Vincristine. - Vinorelbine. ASCO provides a summary of oral ...
- ... or anal carcinoma include:[ 3 , 5 ] ... (MVAC). Paclitaxel. Carboplatin. Ifosfamide, with occasional ...
8 results